Phase 2 Trial Now Underway for GLPG1205

This topic contains 0 replies, has 1 voice, and was last updated by  Pulmonary Fibrosis News Moderator 10 months, 1 week ago.

  • Author
    Posts
  • #15257

    Galapagos has launched a Phase 2 trial testing the safety and effectiveness of investigational therapy GLPG1205 for idiopathic pulmonary fibrosis. Click here to find out more.

    Are you interested in more news about this study?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account